Related Experiment Video
Updated: Aug 5, 2025

Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues
Published on: October 17, 2022
A Fluid Multivalent Magnetic Interface for High-Performance Isolation and Proteomic Profiling of Tumor-Derived
Qi Niu1, Yun Shu2, Yuanqiang Chen3
1The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, the Key Laboratory of Chemical Biology of Fujian Province, State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Centre of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, China.
We developed FluidmagFace, a microfluidic chip for isolating tumor-derived extracellular vesicles (T-EVs). This technology enhances T-EV detection sensitivity and enables efficient protein analysis for improved cancer diagnosis and biomarker discovery.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Tumor-derived extracellular vesicles (T-EVs) are crucial biomarkers for cancer management.
- Efficient isolation and analysis of T-EVs are essential for clinical applications.
- Current methods face challenges in sensitivity and throughput.
Purpose of the Study:
- To develop a novel microfluidic chip for high-performance isolation, release, and protein profiling of T-EVs.
- To enhance the efficiency, sensitivity, and throughput of T-EV analysis.
- To facilitate T-EV detection and biomarker discovery for cancer diagnosis.
Main Methods:
- Development of a fluid multivalent magnetic interface (FluidmagFace) integrated into a microfluidic chip.
- Utilizing fluidity-enhanced multivalent binding for increased T-EV affinity and isolation efficiency.
- Employing anti-adsorption properties and hydrodynamic shear to minimize contamination and enhance detection sensitivity.
- Implementing reversible and expandable features for high-throughput T-EV recovery for mass spectrometry.
Main Results:
- FluidmagFace demonstrated a 10^5-fold increase in affinity and a 13.9% improvement in isolation efficiency compared to non-fluid interfaces.
- Detection sensitivity was increased by two orders of magnitude due to minimized contamination.
- T-EVs were successfully detected in all tested cancer samples.
- Differentially expressed proteins were identified in cancer samples compared to healthy controls.
Conclusions:
- The FluidmagFace microfluidic chip offers a high-performance solution for T-EV isolation, release, and protein analysis.
- This technology significantly improves T-EV detection sensitivity and enables high-throughput analysis.
- FluidmagFace represents a promising new approach for cancer diagnosis and biomarker discovery.
More Related Videos
09:28Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
Published on: October 27, 2023
06:12Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023